Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cynthia Ma, M.D., Ph.D
Washington University School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bc Cancer Agency
Vancouver, British Columbia, Canada
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- University of Alabama Cancer Center
Birmingham, Alabama, United States
- Mayo Clinic
Phoenix, Arizona, United States
- University of Southern California Keck School of Medicine
Los Angeles, California, United States
- Stanford Medicine Cancer Institute
Stanford, California, United States
- University of Miami Hospital and Clinics
Miami, Florida, United States
- Northwestern University - Feinberg School of Medicine
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Dana-Farber Cancer Institute, Harvard University
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- St. Luke'S Cancer Institute
Kansas City, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- University of North Carolina at Chapel Hill (lineberger Comprehensive Cancer Center)
Chapel Hill, North Carolina, United States
- Duke Cancer Institute at Duke University Medical Center
Durham, North Carolina, United States
- Avera Cancer Institute
Sioux Falls, South Dakota, United States
- Baylor College of Medicine
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Dec 2012
- Primary completion
- 11 Feb 2021
- Completion
- 11 Mar 2021
- Last update posted
- 15 Apr 2022
- Registered enrollment
- 56
- Registry id
- NCT01670877
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.